These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 7778265)

  • 1. Generation of thymidine kinase-deficient mutants of infectious laryngotracheitis virus.
    Schnitzlein WM; Winans R; Ellsworth S; Tripathy DN
    Virology; 1995 Jun; 209(2):304-14. PubMed ID: 7778265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity and vaccine efficacy of a thymidine kinase gene deleted infectious laryngotracheitis virus expressing the green fluorescent protein gene.
    Han MG; Kweon CH; Mo IP; Kim SJ
    Arch Virol; 2002 May; 147(5):1017-31. PubMed ID: 12021870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of recombinant avian infectious laryngotracheitis virus expressing the beta-galactosidase gene and DNA sequencing of the insertion region.
    Guo P; Scholz E; Maloney B; Welniak E
    Virology; 1994 Aug; 202(2):771-81. PubMed ID: 8030240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the thymidine kinase gene of infectious laryngotracheitis virus.
    Keeler CL; Kingsley DH; Burton CR
    Avian Dis; 1991; 35(4):920-9. PubMed ID: 1664722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo characterization of glycoprotein C-deleted infectious laryngotracheitis virus.
    Pavlova SP; Veits J; Blohm U; Maresch C; Mettenleiter TC; Fuchs W
    J Gen Virol; 2010 Apr; 91(Pt 4):847-57. PubMed ID: 19940061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propagation of infectious laryngotracheitis virus in an avian liver cell line.
    Schnitzlein WM; Radzevicius J; Tripathy DN
    Avian Dis; 1994; 38(2):211-7. PubMed ID: 7980266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology of avian infectious laryngotracheitis virus.
    Fuchs W; Veits J; Helferich D; Granzow H; Teifke JP; Mettenleiter TC
    Vet Res; 2007; 38(2):261-79. PubMed ID: 17296156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The non-essential UL50 gene of avian infectious laryngotracheitis virus encodes a functional dUTPase which is not a virulence factor.
    Fuchs W; Ziemann K; Teifke JP; Werner O; Mettenleiter TC
    J Gen Virol; 2000 Mar; 81(Pt 3):627-38. PubMed ID: 10675400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Diversity of Infectious Laryngotracheitis Virus during
    Loncoman CA; Hartley CA; Coppo MJC; Vaz PK; Diaz-Méndez A; Browning GF; García M; Spatz S; Devlin JM
    Appl Environ Microbiol; 2017 Dec; 83(23):. PubMed ID: 28939604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.
    Coppo MJ; Noormohammadi AH; Hartley CA; Gilkerson JR; Browning GF; Devlin JM
    Avian Pathol; 2011 Aug; 40(4):411-7. PubMed ID: 21812721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marek's disease virus protein kinase gene identified within the short unique region of the viral genome is not essential for viral replication in cell culture and vaccine-induced immunity in chickens.
    Sakaguchi M; Urakawa T; Hirayama Y; Miki N; Yamamoto M; Zhu GS; Hirai K
    Virology; 1993 Jul; 195(1):140-8. PubMed ID: 8391181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine.
    Devlin JM; Browning GF; Hartley CA; Gilkerson JR
    Vaccine; 2007 May; 25(18):3561-6. PubMed ID: 17316926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the complete genome sequences of two Australian origin live attenuated vaccines of infectious laryngotracheitis virus.
    Lee SW; Devlin JM; Markham JF; Noormohammadi AH; Browning GF; Ficorilli NP; Hartley CA; Markham PF
    Vaccine; 2011 Dec; 29(52):9583-7. PubMed ID: 22044743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication-independent reduction in the number and diversity of recombinant progeny viruses in chickens vaccinated with an attenuated infectious laryngotracheitis vaccine.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Quinteros JA; Diaz-Méndez A; Thilakarathne D; Fakhri O; Vaz PK; Devlin JM
    Vaccine; 2018 Sep; 36(38):5709-5716. PubMed ID: 30104116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
    Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the safety and protective efficacy of vaccination with glycoprotein-G-deficient infectious laryngotracheitis virus delivered via eye-drop, drinking water or aerosol.
    Devlin JM; Browning GF; Gilkerson JR; Fenton SP; Hartley CA
    Avian Pathol; 2008 Feb; 37(1):83-8. PubMed ID: 18202954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Korean strains of infectious laryngotracheitis virus by nucleotide sequences and restriction fragment length polymorphism.
    Han MG; Kim SJ
    Vet Microbiol; 2001 Dec; 83(4):321-31. PubMed ID: 11600266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
    Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.